Article thumbnail
Location of Repository

Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients - Fig 3

By José Luis García de Veas Silva (3366677), Carmen Bermudo Guitarte (3366668), Paloma Menéndez Valladares (3366674), Johanna Carolina Rojas Noboa (3366680), Krysta Kestler (3366671) and Rafael Duro Millán (3366683)

Abstract

<p>A) Overall Survival (OS) of all patients based on International Staging System (ISS) (n = 180). B) OS of patients in ISS-1 stratified by sFLCR (n = 56). C) OS of patients in ISS-2 stratified by sFLCR (n = 65). D) OS of patients in ISS-3 stratified by sFLCR (n = 59).</p

Topics: Medicine, Cell Biology, Biotechnology, Cancer, 72 disease-related deaths, MM patients, 2M, sCR, HR, CR -52 months, prognostic value, ROC, Multiple Myeloma Patients Background, risk stratification model, ISS, Disease Free Survival, NR, Serum Free Light Chains Measurements, 5- years OS, CI, DFS, Methods 180 patients, sFLCR, IC, PFS, sFLC ratio
Year: 2016
DOI identifier: 10.1371/journal.pone.0166841.g003
OAI identifier: oai:figshare.com:article/4267886
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.